Wordt geladen...
Sudden Cardiac Death in Haemodialysis Patients under Hydroxychloroquine Treatment for COVID-19: A Report of Two Cases
Hydroxychloroquine (HQ) has been used for the treatment of novel coronavirus disease (COVID-19) even though there is no clear evidence for its effectiveness yet. In contrary, HQ has major side effects like QTc prolongation and subsequent development of ventricular arrhythmias. Such side effects may...
Bewaard in:
| Gepubliceerd in: | Blood Purif |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649688/ https://ncbi.nlm.nih.gov/pubmed/33032282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511392 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|